Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment - Takei, Satomi; Ai, Tomohiko; Yamamoto, Takamasa; Igawa, Gene; Kanno, Takayuki; Tobiume, Minoru; Hiki, Makoto; Saito, Kaori; Khasawneh, Abdullah; Wakita, Mitsuru; Misawa, Shigeki; Miida, Takashi; et al. (PloS one, 2022)
Keywords: Antibodies; Anticoagulants; Antiviral agents; Antiviral drugs; Assaying; Biology and Life Sciences; Coronaviruses; Correlation; COVID-19; Evaluation; FDA approval; Health aspects; Immune status; Immunoassay; Immunoassays; Medicine and Health Sciences; Neutralization; Neutralizing; Patients; Performance evaluation; Proteins; Regression analysis; Research and Analysis Methods; Serology; Serum; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Vaccines; Viral antibodies; Viral diseases; Viruses; Japan; United States--US; Switzerland